PROSTHETIC HEART VALVE MARKET ANALYSIS

The prosthetic heart valve market faces several challenges. Currently used mechanical valves have lifelong blood thinning medication requirements which can lead to health issues. Tissue valves have limited durability requiring reoperations. Developing biomaterial alternatives that do not require chronic anticoagulation therapy or have improved durability has been difficult. Reimbursement policies also present a challenge as not all newer valve technologies have established payment codes. The need for extensive clinical trials increases costs and time to market for innovators.

 Market Opportunities: Minimally invasive procedures are on the rise

The growing geriatric population susceptible to valvular heart disease will drive demand. Transcatheter aortic valve replacement minimally invasive procedures are on the rise allowing the treatment of inoperable patients. Newer bioprosthetic valves could provide durable alternatives to mechanical ones reducing health risks. Developing valves compatible for pediatric patients are expected to create lucrative opportunities for market development over the forecasted period.